Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Castle Biosciences Inc. (CSTL) Appoints Kim Caple and Ellen Goldberg to its Board
-
DiaMedica Therapeutics Inc. (DMAC) Appoints Amy Burroughs and Charles Semba to its Board
-
Recruiter.com Group (RCRT) Appoints Xuan Smith as Chief Technology Officer
-
Ligand Pharma (LGND) Appoints Jennifer Cochran to its Board
-
WM Technology, Inc (MAPS) Announces it Board of Directors
-
Flexion Therapeutics (FLXN) Appoints Utpal Koppikar to its Board
-
NIO Inc. (NIO) Appoints Ms. Yu Long as Independent Director
-
MasterCraft (MCFT) Appoints Jennifer Deason to its Board
-
VinBrain wins ACM SIGAI Industry Award 2021 for Excellence in Artificial Intelligence
-
WRAP Technologies (WRAP) Appoints Glenn Hickman as COO
-
Eledon Pharmaceuticals (ELDN) Appoints Jan Hillson to its Board
-
FirstEnergy (FE) Appoints Lisa Winston Hicks and Paul Kaleta to its Board
-
Alpine Immune Sciences (ALPN) to Collaborate with Merck (MRK) on Immuno-Oncology Study to Evaluate ALPN-202 in Combination with KEYTRUDA
-
Stanford Sonoma is Pleased to Announce Online Restaurant Supplies
-
Stanford Sonoma is Pleased to Announce Online Restaurant Supplies
-
Mind Medicine (MNMD) Appoints Maurizio Fava to its Board
-
Dril-Quip (DRQ) Announces Addition to its Board of Directors
-
Gossamer Bio Inc. (GOSS) Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer
-
Amazon (AMZN) in Talks to Acquire Stake in Self-Driving Truck Startup Plus: Report
-
J2 Global (JCOM) Announces Trace Harris Appointed to Board of Directors
-
TG Therapeutics (TGTX) Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at EAN
-
TCW Special Purpose Acquisition Corp. (TSPQ) Appoints David W. Rye to its Board
-
L Brands (LB) Announces Board of Directors for Standalone Victoria's Secret
-
First Look Media, Inc. (FRST) Appoints Allen Jones and John Eggemeyer to its Board
-
Blue Cross and Blue Shield of Minnesota Names Matt Hunt as Chief Experience Officer
-
Electronic Arts (EA) Nomirates Kofi A. Bruce to its Board
-
Luminar Technologies (LAZR) Appoints Jun Hong Heng and Dr. Shaun Maguire to its Board
-
1Life Healthcare (ONEM) Adds Scott C. Taylor to Board
-
BeyondSpring (BYSI) to Present Three Abstracts from PROTECTIVE-2 Phase 3 Trials of Plinabulin at ASCO
-
Magenta Therapeutics (MGTA) Announces Additional Preliminary Positive Results from Ongoing Phase 2 Clinical Trial of MGTA-145 and Plerixafor in Patients with Multiple Myeloma at ASCO
-
DermTech (DMTK) Appoints Three New Scientific Advisors to its Board
-
Stanford Equipment Launches Ecommerce Website
-
Stanford Equipment Launches Ecommerce Website
-
Alpine Immune Sciences (ALPN) Appoints Zelanna Goldberg, M.D., M.A.S. as Chief Medical Officer
-
Colgate Eliminates Tuition for Families With Incomes Less Than $80,000
-
Adverum Biotechnologies (ADVM) Appoints CMO and CSO
-
Alliance Data Systems (ADS) Names Karin Kimbrough to Board
-
Stanford Libraries receives an important East Asian information technology collection
-
NRx Pharmaceuticals (NRXP) Names General H.R. McMaster to Company's Board of Directors
-
Okta, Inc. (OKTA) Welcomes Experienced Financial Executive Jeff Epstein to Board of Directors
-
California Water Service (CWT) Reports Election of Dr. Bonnie Maldonado to Board
-
Chris Womack named chairman and CEO of Georgia Power (SO)
-
Abeona Therapeutics (ABEO) Issues Letter to Stockholders
-
AptarGroup (ATR) Names Candace Matthews to Board
-
Torex Gold Announces Proposed Changes to Its Board of Directors
-
Aviat Networks (AVNW) Appoints Michele Klein to its Board of Directors
-
StoneCo (STNE) Announces New Members of the Board of Directors and the Creation of New Board Committees
-
Rocket Pharmaceuticals (RCKT) Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at ASGCT
-
Magenta Therapeutics (MGTA) Announces Positive Preliminary Results from Phase 2 Clinical Trial of MGTA-145 in Multiple Myeloma and Provides an Update on its Anticipated Clinical Study with MGTA-117
-
Stanford University Orthopedic Study Collaboration with Endonovo Therapeutics SofPulseĀ® Devices Moves Forward

